2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The …

…, D Jiménez, N Kucher, IM Lang… - European heart …, 2020 - academic.oup.com
determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the individual …

Cellular and molecular pathobiology of pulmonary arterial hypertension

…, KR Stenmark, MR MacLean, IM Lang… - Journal of the American …, 2004 - jacc.org
Pulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction,
remodeling of the pulmonary vessel wall, and thrombosis contribute to increased pulmonary …

Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension

…, RN Channick, PM Hassoun, IM Lang… - Journal of the American …, 2009 - jacc.org
The 4th World Symposium on Pulmonary Hypertension was the first international meeting to
focus not only on pulmonary arterial hypertension (PAH) but also on the so-called non-PAH …

2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European …

…, GP Diller, B Lung, J Kluin, IM Lang… - European heart …, 2021 - academic.oup.com
Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during …

…, U Kintscher, P Kranke, IM Lang… - European heart …, 2018 - academic.oup.com
not override in any way whatsoever the individual responsibility of health professionals to
make appropriate and accurate decisions in consideration of each patient’s health condition …

[HTML][HTML] Fibrinolysis for patients with intermediate-risk pulmonary embolism

…, M Kozak, C Kupatt, N Kucher, IM Lang… - … England Journal of …, 2014 - Mass Medical Soc
Background The role of fibrinolytic therapy in patients with intermediate-risk pulmonary
embolism is controversial. Methods In a randomized, double-blind trial, we compared …

[HTML][HTML] Selexipag for the treatment of pulmonary arterial hypertension

…, HA Ghofrani, MM Hoeper, IM Lang… - … England Journal of …, 2015 - Mass Medical Soc
Background In a phase 2 trial, selexipag, an oral selective IP prostacyclin-receptor agonist,
was shown to be beneficial in the treatment of pulmonary arterial hypertension. Methods In …

Opening mechanisms of the human upper esophageal sphincter

…, B Massey, MK Kern, IM Lang… - American Journal …, 1989 - journals.physiology.org
Our goals in this study were to evaluate the mechanisms operative in swallow-associated
opening of the upper esophageal sphincter (UES) and to determine the dynamics of fluid flow …

Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic …

…, M Delcroix, HA Ghofrani, MM Hoeper, IM Lang… - Journal of the American …, 2008 - jacc.org
Objectives : Our goal was to investigate the effect of treatment with the oral dual endothelin
receptor antagonist bosentan on the hemodynamics and exercise capacity of patients with …

Effect of swallowed bolus variables on oral and pharyngeal phases of swallowing

…, JG Brasseur, IJ Cook, IM Lang - American Journal …, 1990 - journals.physiology.org
In this investigation, we studied the effects of bolus volume and viscosity on the quantitative
features of the oral and pharyngeal phases of swallowing. Concurrent videofluoroscopic and …